Proliferation of rat small hepatocytes requires follistatin expression

Journal of Cellular Physiology

Volumn 227, Issue 6, 2012, Pages 2363-2370

  Ooe, Hidekazu ^a   Chen, Qijie ^a   Kon, Junko ^a   Sasaki, Kazunori ^a   Miyoshi, Hiroyuki ^b   Ichinohe, Norihisa ^a   Tanimizu, Naoki ^a   Mitaka, Toshihiro ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b RIKEN BIORESOURCE CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN A; DNA; FOLLISTATIN; MYELOPID; PROTEIN ANTIBODY; SHORT HAIRPIN RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL CULTURE; CELL GROWTH; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; CYTOPLASM; DNA SYNTHESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HOMEOSTASIS; IMMUNOCYTOCHEMISTRY; LIVER CELL; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMALL HEPATOCYTE; WESTERN BLOTTING;

ACTIVINS; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SIZE; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; DNA REPLICATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FOLLISTATIN; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HEPATOCYTES; IMMUNOHISTOCHEMISTRY; LIVER; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RATS; RATS, INBRED F344; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TIME FACTORS; TRANSFECTION;

RATTUS;

EID: 84857466760     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22971     Document Type: Article

References (41)

1. Bartholin L, Maguer-Satta V, Hayette S, Martel S, Gadoux M, Corbo L, et al. 2002. Transcription activation of FLRG and follistatin by activin A, through Smad proteins, participates in a negative feedback loop to modulate activin A function. Oncogene 21: 2227-2235.
2. Best DH, Coleman WB. 2007. Bile duct destruction by 4, 4′-diaminodipheylmethane does not block the small hepatocyte-like progenitor cell response in retrorsine-exposed rats. Hepatology 46: 1611-1619.
3. Chen Q, Kon J, Ooe H, Sasaki K, Mitaka T. 2007. Selective proliferation of rat hepatocyte progenitor cells in serum-free culture. Nat Protocol 2: 1197-1205.
4. + head and neck squamous cell carcinoma cells. Head Neck (in press).
5. Clark JB, Rice L, Sadiq T, Brittain E, Song L, Wang J, Gerber DA. 2005. Hepatic progenitor cell resistance to TGF-β1's proliferative and apoptotic effects. Biochem Biophys Res Commun 329: 337-344.
6. + liver cancer stem cells from methionine adenosyl transferase 1A-deficient mice demonstrate resistance to transforming growth factor (TGF)-β-induced apoptosis. Hepatology 49: 1277-1286.
7. Endo D, Maku-Uchi M, Kojima I. 2006. Activin or follistatin: Which is more beneficial to support liver regeneration after massive hepatectomy? Endocr J 53: 73-78.
8. Goodison S, Urquidi V, Tarin D. 1999. CD44 cell adhesion molecules. J Clin Pathol Mol Pathol 52: 189-196.
9. Gordon GJ, Coleman WB, Hixson DC, Grisham JW. 2000. Liver regeneration in rats with retrorsine-induced hepatocellular injury proceeds through a novel cellular response. Am J Pathol 156: 607-619.
10. Hayashi M, Maeda S, Aburatani H, Kitamura K, Miyoshi H, Miyazono K, et al. 2008. Pitx2 prevents osteoblastic transdifferentiation of myoblasts by bone morphogenetic proteins. J Biol Chem 283: 565-571.
11. Hully JR, Chang L, Schwall RH, Widmer HR, Terrel TG, Gillett NA. 1994. Induction of apoptosis in the murine liver with recombinant human activin A. Hepatology 20: 854-862.
12. Ichikawa T, Zhan YQ, Kogure K, Hasegawa Y, Takagi H, Mori M, et al. 2001. Transforming growth factor beta and activin tonically inhibit DNA synthesis in the rat liver. Hepatology 34: 918-925.
13. Katayama K, Wada K, Miyoshi H, Ohashi K, Tachibana M, Furuki R, et al. 2004. RNA interfering approach for clarifying the PPARγ pathway using lentiviral vector expressing short hairpin RNA. FEBS Lett 560: 178-182.
14. Keysar SB, Jimeno A. 2010. More than markers: Biological significance of cancer stem cell-defining molecules. Mol Cancer Ther 9: 2450-2457.
15. Kogure K, Omata W, Kanzaki M, Zhang YQ, Yasuda H, Mine T, et al. 1995. A single intraportal administration of follistatin accelerates liver regeneration in partially hepatectomized rats. Gastroenterology 108: 1136-1142.
16. Kogure K, Zhang YQ, Kanzaki M, Omata W, Mine T, Kojima I. 1996. Intravenous administration of follistatin: Delivery to the liver and effect on liver regeneration after partial hepatectomy. Hepatology 24: 361-366.
17. Kogure K, Zhang YQ, Maeshima A, Suzuki K, Kuwano H, Kojima I. 2000. The role of activin and transforming growth factor-beta in the regulation of organ mass in the rat liver. Hepatology 31: 916-921.
18. Kon J, Ooe H, Oshima H, Kikkawa Y, Mitaka T. 2006. Expression of CD44 in rat hepatic progenitor cells. J Hepatol 45: 90-98.
19. Kreidl E, Oztürk D, Metzner T, Berger W, Grusch M. 2009. Activins and follistatins: Emerging roles in liver physiology and cancer. World J Hepatol 1: 17-27.
20. Mather JKP, Moore A, Li RH. 1997. Activins, inhibins and follistatins: Further thoughts on a growth family of regulators. Proc Soc Exp Biol Med 215: 209-222.
21. Mitaka T, Sattler CA, Sattler GL, Sargent LM, Pitot HC. 1991. Multiple cell cycles occur in rat hepatocytes cultured in the presence of nicotinamide and epidermal growth factor. Hepatology 13: 21-30.
22. Mitaka T, Mikami M, Sattler GL, Pitot HC, Mochizuki Y. 1992. Small cell colonies appear in the primary culture of adult rat hepatocytes in the presence of nicotinamide and epidermal growth factor. Hepatology 16: 440-447.
23. Mitaka T, Kojima T, Mizuguchi T, Mochizuki Y. 1995. Growth and maturation of small hepatocytes isolated from adult liver. Biochem Biophys Res Commun 214: 310-317.
24. Mitaka T, Sato F, Mizuguchi T, Yokono T, Mochizuki Y. 1999. Reconstruction of hepatic organoid by rat small hepatocytes and hepatic nonparenchymal cells. Hepatology 29: 111-125.
25. Miyamoto S, Hirata K, Sugimoto S, Harada K, Mitaka T. 2005. Expression of cytochrome P450 enzymes in hepatic organoid reconstructed by rat small hepatocytes. J Gastroenterol Hepatol 20: 865-872.
26. Nguyen LN, Furuya MH, Wolfraim LA, Nguyen AP, Holdren MS, Campbell JS, Knight B, Yeoh GC, Fausto N, Parks WT. 2007. Transforming growth factor-beta differentially regulates oval cell and hepatocyte proliferation. Hepatology 45: 31-41.
27. Niimi S, Hyuga M, Kazama H, Inagawa M, Seki T, Ariga T, Kobayashi T, Hayakawa T. 2002. Activins A, AB, and B inhibit hepatocyte growth factor synthesis by MRC-5 human lung fibroblasts. Biol Pharm Bull 25: 1405-1408.
28. Park SH. 2005. Fine tuning and cross-talking of TGF-beta signal by inhibitory Smads. J Biochem Mol Biol 38: 9-16.
29. Phillips DJ. 2000. Regulation of activin's access to the cell: Why is Mother Nature such a control freak? Bioessays 22: 689-696.
30. Pichard V, Ferry N. 2008. Origin of small hepatocyte-like progenitor in retrorsine-treated rats. J Hepatol 48: 368-369.
31. Rodgarkia-Dara C, Vejda S, Erlach N, Losert A, Bursch W, Berger W, et al. 2006. The activin axis in liver biology and disease. Mut Res 613: 123-137.
32. Schneyer A, Schoen A, Quigg A, Sidis Y. 2003. Differential binding and neutralization of activins A and B by follistatin and follistatin like-3 (FSTL-3/FSRP/FLRG). Endocrinology 144: 1671-1674.
33. Schwall RH, Robbins K, Jardieu P, Chang L, Lai C, Terrell TG. 1993. Activin induces cell death in hepatocytes in vivo and in vitro. Hepatology 18: 347-356.
34. Sugimoto S, Mitaka T, Ikeda S, Harada K, Ikai I, Yamaoka Y, et al. 2002. Morphological changes induced by extracellular matrix are correlated with maturation of rat small hepatocytes. J Cell Biochem 87: 16-28.
35. Takabe K, Wang L, Leal AM, Macconell LA, Wiater E, Tomiya T, et al. 2003. Adenovirus-mediated overexpression of follistatin enlarges intact liver of adult rats. Hepatology 38: 1107-1115.
36. Tateno C, Yoshizato K. 1996. Growth and differentiation in culture of clonogenic hepatocytes that express both phenotypes of hepatocytes and biliary epithelial cells. Am J Pathol 148: 1593-1605.
37. Tuuri T, Erämaa M, Hildén K, Ritvos O. 1994. The tissue distribution of activin beta A- and beta B-subunit and follistatin messenger ribonucleic acids suggests multiple sites of action for the activin-follistatin system during human development. J Clin Endocrinol Metab 78: 1521-1524.
38. Xu J, McKeehan K, Matsuzaki K, McKeehan WL. 1995. Inhibin antagonizes inhibition of liver cell growth by activin by a dominant-negative mechanism. J Biol Chem 270: 6308-6313.
39. Yamamoto T, Miyoshi H, Yamamoto N, Yamamoto N, Inoue J, Tsunetsugu-Yokota Y. 2006. Lentivirus vectors expressing short hairpin RNAs against the U3-overlapping region of HIV nef inhibit HIV replication and infectivity in primary macrophages. Blood 108: 3305-3312.
40. Yasuda H, Mine T, Shibata H, Eto Y, Hasegawa Y, Takeuchi T, et al. 1994. Activin A: An autocrine inhibitor of initiation of DNA synthesis in rat hepatocytes. J Clin Invest 92: 1491-1496.
41. Zöller M. 2011. CD44: Can a cancer-initiating cell profit from an abundantly expressed molecule? Nat Rev Cancer 11: 254-267.